Corporate Symposia Series
Available to ARRS 2021 Virtual Annual Meeting registrants only. Registration for the Corporate Symposia will be available on the ARRS Meeting Portal beginning April 12.
2021 ARRS Virtual Meeting
The Corporate Symposia are not part of the ARRS CME program and ARRS has had no role in the development of the content. Any opinions or conclusions expressed are solely those of the presenters. Where noted, CME is made available by third party providers. Credit must be claimed through the accrediting organization and separately from your ARRS Annual Meeting credit.
Monday, April 19, 12:00–1:00 pm
Exploring the Role of Radiologists in Diagnosis and Monitoring of VOD/SOS: An Illustrative Case Discussion
THIS ACTIVITY IS SUPPORTED BY AN INDEPENDENT EDUCATIONAL GRANT FROM JAZZ PHARMACEUTICALS, INC.
This CME activity is jointly provided by PER, Physicians' Education Resource, LLC.
Sherwin S. Chan, MD, PhD
Vice Chair, Radiology
Children’s Mercy Kansas City
Kansas City, MO
Manjiri Dighe, MD, MBBS
Medical Director of Ultrasound
Department of Radiology
University of Washington
Vincent T. Ho, MD
Associate Professor of Medicine, Harvard Medical School
Director of Clinical Operations, Adult Allogeneic Stem Cell Transplantation
Dana-Farber Cancer Institute
Early detection of VOD/SOS and prompt initiation of treatment are critical to optimize patient management. The strategic implementation of various imaging modalities could help predict the risk of VOD/SOS, facilitate and confirm a diagnosis, and monitor progression before and after treatment. Given the significant role radiologist play in the diagnosis as well as treatment monitoring of patients with VOD/SOS, it is important for radiologists to understand not just the evolving diagnostic criteria and imaging modalities but also the underlying pathophysiology of VOD/SOS as well as currently available therapies.
Exploring the Role of Radiologists in Diagnosis and Monitoring of VOD/SOS: An Illustrative Case Discussion is a virtual symposium that mainly uses clinical case discussions to provide insights from experts on important topics such as updates on recent practice-changing guidelines and evidence in diagnosing and monitoring VOD/SOS through multidisciplinary care with a radiologist. The agenda will utilize a case-based educational design that covers updates for multidisciplinary teams, applying evidence across the continuum.
Tuesday, April 20, 12:00–1:00 pm
The Importance of Early Recognition of ILDs
THIS ACTIVITY IS SUPPORTED BY AN INDEPENDENT EDUCATIONAL GRANT FROM BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
This CME activity is jointly provided by PVI, PeerView Institute for Medical Education.
Brett Elicker, MD
Clinical Professor of Radiology
Department of Radiology & Biomedical Imaging
University of California
San Francisco, California
Mary M. Salvatore, MD
Associate Professor of Radiology
Columbia University Irving Medical Center
New York, New York
Joshua J. Solomon, MD
Associate Professor of Medicine
Autoimmune Lung Center and Interstitial Lung Disease Program
National Jewish Health
Optimal treatment of interstitial lung diseases (ILDs)—including idiopathic pulmonary fibrosis (IPF), systemic sclerosis–associated ILD (SSc-ILD), and chronic fibrosing ILD (CF-ILD)—relies on early recognition and accurate diagnosis. High-resolution computed tomography (HRCT) and a familiarity with the usual appearances of these conditions is necessary for a timely diagnosis. However, ILD presentation is often heterogeneous and a multidisciplinary consensus is often essential.
For this live web broadcast, PeerView has assembled a panel of experts to guide clinicians towards effectively identifying and diagnosing these interstitial lung disorders. The faculty will describe signs and symptoms of ILDs—including IPF, SSc-ILD, and CF-ILD— and how to interpret radiographic patterns on HRCT to facilitate an accurate diagnosis. They will also discuss the importance of the multidisciplinary team and share experiences and lessons from their own practices to offer practical strategies.